Tag: Research/Development

J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decision

Johnson & Johnson became the latest COVID-19 vaccine maker to offer an update on booster doses Tuesday, when it said data from a Phase 3...

Opinion: If you want to fix climate change, you need to fix this flaw in conventional economic thought

BRUSSELS, Belgium (Project Syndicate)—Nowhere are the limitations of neoclassical economic thinking—the DNA of economics as it is currently taught and practiced—more apparent than in the...

India is the number one country in Asia for Polish investors: Envoy

Poland has been among India’s key Central European partners over the past seven decades. And in the last few years has witnessed penetration of Indian...

Pharma industry warns against interfering with COVID vaccine shot intervals

U.S. and European pharmaceutical industry organizations on Wednesday urged governments not to extend the delays prescribed by COVID-19 vaccine developers between the first and second...

World watches as first person receives Pfizer-BioNTech COVID shot

Manufacturing delays mean just 4 million doses of the vaccine candidate being developed by drugmaker AstraZeneca AZN, +0.97% and the University of Oxford will be...

I’m already trying out a COVID vaccine. But can I get another one injected, in case it was a placebo?

A sign calling for participants on the Research Centers of America vaccine study during the Phase 3 COVID-19 trial of the Moderna vaccine in Hollywood,...

When can I get a COVID-19 vaccine? Will the shots be free? Your vaccine questions, answered

Pfizer and Moderna are both developing a messenger ribonucleic acid (mRNA) vaccine, a new kind of vaccine that teaches cells to create proteins that generate...

This is why I volunteered for the Novavax COVID-19 vaccine trial, and am still cheering for the underdog

Novavax, headquartered in Rockville, Md., was the second company to enter into a late-stage trial of a COVID vaccine in the U.K. AFP via Getty...

Older people, Black and Latinx Americans say they would be hesitant about getting a coronavirus vaccine

Some 46% of Americans ages 50 to 80 would rather wait for others to get vaccinated first before doing it themselves, according to a recent...

Is upbeat COVID-vaccine news priced into the market?

A growing list of vaccine candidates have rolled out in recent weeks, offering the world a potential exit from a global pandemic nightmare that has...

Dow, S&P 500 surge by at least 3% to records early Monday on coronavirus vaccine report

U.S. stocks soared in early trading Monday, sending major equity benchmarks to record highs after Germany-based BioNTech SE and Pfizer Inc. said their COVID-19 vaccine...

There are four coronavirus vaccines in late-stage studies — here’s how they differ

Johnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so...